Semaphorin 7A on keratinocytes induces interleukin-8 production by monocytes.

M. Kamata,Y. Tada,H. Uratsuji,T. Kawashima,Y. Asano,M. Sugaya,T. Kadono,K. Tamaki,S. Sato

DOI: https://doi.org/10.1016/j.jdermsci.2011.02.004

2011-06-01

Abstract:

What problem does this paper attempt to address?

Preparation of chitosan-based multifunctional nanocarriers overcoming multiple barriers for oral delivery of insulin.

Lei Li,Guohua Jiang,Weijiang Yu,Depeng Liu,Hua Chen,Yongkun Liu,Zaizai Tong,Xiangdong Kong,Juming Yao

DOI: https://doi.org/10.1016/j.msec.2016.08.083

2016-01-01

Abstract:To overcome multiple barriers for oral delivery of insulin, the chitosan-based multifunctional nanocarriers modified by L-valine (LV, used as a target ligand to facilitate the absorption of the small intestine) and phenylboronic acid (PBA, used as a glucose-responsive unit) have been designed and evaluated in this study. The resultant nanocarriers exhibited low cytotoxicity against HT-29 cells and excellent stability against protein solution. The insulin release behaviors were evaluated triggered by pH and glucose in vitro. The chemical stability of loaded insulin against digestive enzyme were established in presence of simulated gastric fluid (SGF) containing pepsin and simulated intestinal fluid (SIF) containing pancreatin, respectively. The uptake behavior of HT-29 cells was evaluated by confocal laser scanning microscope. After oral administration to the diabetic rats, an effective hypoglycemic effect was obtained compared with subcutaneous injection of insulin. This work suggests that L-valine modified chitosan-based multifunctional nanocarriers may be a promising drug delivery carrier for oral administration of insulin.
Dually-crosslinked Degradable Polyionic Micelles for Sustained Glucose-responsive Insulin Release

Yuhong Ma,Yu Xing,Fuwei Han,Jiahao Xu,Hongliang Qian,Wei Chen,Dechun Huang

DOI: https://doi.org/10.1039/d4bm00314d

2024-05-01

Biomaterials Science

Abstract:The glucose-sensitive delivery system holds great promise as a therapeutic approach for high-incidence diabetes due to its ability to release insulin whenever elevated glycemia. However, it still faces the instability problem under hyperglycemic environment, which leads to the short time of sustained insulin release. Herein, we designed dually-crosslinked insulin polyionic micelles (DCM@insulin) based on triblock polymers of o-glycol and phenylboronic acid-functionalized poly(ethylene glycol)-poly(dimethylamino carbonate)-poly (dimethylamino-trimethylene carbonate) (mPEG-P(AC-co-MPD)-PDMAC and mPEG-P(AC-co-MAPBA)-PDMATC, respectively) for sustained glucose-responsive insulin release. DCM@insulin with phenylboronic acid ester structure (first crosslinking structure) enhanced glycemic responsiveness by regulating insulin release under hyperglycemic environment. Additionally, the UV-crosslinking structure (second crosslinking structure) by the residual double bonds in AC units endowed DCM@insulin with the ability to effectively protect the loaded insulin against protease degradation and avoid burst release under multiple insulin release. The in vivo findings demonstrated that DCM@insulin effectively maintained glycemic levels (BGLs) within the normal range for 6 h in comparison to single-crosslinked micelles (SCM@insulin). Therefore, the glucose-responsive and dually-crosslinked polyionic micelles system exhibits potential as a viable option for treatment of diabetes.

materials science, biomaterials
Zwitterionic micelles efficiently deliver oral insulin without opening tight junctions

Xiangfei Han,Yang Lu,Jinbing Xie,Ershuai Zhang,Hui Zhu,Hong Du,Ke Wang,Boyi Song,Chengbiao Yang,Yuanjie Shi,Zhiqiang Cao

DOI: https://doi.org/10.1038/s41565-020-0693-6

IF: 38.3

2020-06-01

Nature Nanotechnology

Abstract:Oral delivery of protein drugs is considered a life-changing solution for patients who require regular needle injections. However, clinical translation of oral protein formulations has been hampered by inefficient penetration of drugs through the intestinal mucus and epithelial cell layer, leading to low absorption and bioavailability, and safety concerns owing to tight junction openings. Here we report a zwitterionic micelle platform featuring a virus-mimetic zwitterionic surface, a betaine side chain and an ultralow critical micelle concentration, enabling drug penetration through the mucus and efficient transporter-mediated epithelial absorption without the need for tight junction opening. This micelle platform was used to fabricate a prototype oral insulin formulation by encapsulating a freeze-dried powder of zwitterionic micelle insulin into an enteric-coated capsule. The biocompatible oral insulin formulation shows a high oral bioavailability of >40%, offers the possibility to fine tune insulin acting profiles and provides long-term safety, enabling the oral delivery of protein drugs.

materials science, multidisciplinary,nanoscience & nanotechnology
A nano-delivery system based on preventing degradation and promoting absorption to improve the oral bioavailability of insulin

Jie Zhou,Jin Zhang,Yiwen Sun,Fusui Luo,Min Guan,Huili Ma,Xiaomeng Dong,Junfen Feng

DOI: https://doi.org/10.1016/j.ijbiomac.2023.125263

2023-07-31

Abstract:Oral insulin delivery can improve patient compliance and simulate the portal-peripheral insulin concentration gradient produced by endogenous insulin, so oral insulin delivery has a broad prospect. However, some characteristics of the gastrointestinal tract, lead to low oral bioavailability. Therefore, a "ternary mutual-assist" nano-delivery system based on poly(lactide-co-glycolide) (PLGA) as the backbone combined with ionic liquids (IL) and vitamin B12-chitosan (VB12-CS) was constructed in this study, the protein protection performance of IL improves the room temperature stability of the loaded insulin during nanocarrier preparation, transportation and storage to a certain extent, and the protein protection function of IL combined with the slow degradation property of PLGA and the pH-responsive function of VB12-CS to prevent the degradation of insulin in the gastrointestinal tract. In addition, the mucosal adhesion function of VB12-CS, VB12 receptor- and clathrin-mediated transcellular transport involving VB12-CS and IL, and paracellular transport mediated by IL and CS can be combined to improve the intestinal epithelial transport efficiency of insulin, thus, the nanocarrier has stronger preventing degradation and promoting absorption effects. Pharmacodynamic studies showed that after oral administration of VB12-CS-PLGA@IL@INS NPs to diabetic mice, the blood glucose level decreased to about 13 mmol/L, below the critical point of 16.7 mmol/L, and the blood glucose reached a normal level, which was 0.4 times of the blood glucose value before administration, its relative pharmacological bioavailability was 31.8 %, higher than the general nanocarriers (10-20 %) and more beneficial to the clinical transformation of oral insulin.
Overcoming Oral Insulin Delivery Barriers: Application of Cell Penetrating Peptide and Silica-Based Nanoporous Composites

Huining He,Junxiao Ye,Jianyong Sheng,Jianxin Wang,Yongzhuo Huang,Guanyi Chen,Jingkang Wang,Victor C. Yang

DOI: https://doi.org/10.1007/s11705-013-1306-9

2013-01-01

Abstract:Oral insulin delivery has received the most attention in insulin formulations due to its high patient compliance and, more importantly, to its potential to mimic the physiologic insulin secretion seen in non-diabetic individuals. However, oral insulin delivery has two major limitations: the enzymatic barrier that leads to rapid insulin degradation, and the mucosal barrier that limits insulin’s bioavailability. Several approaches have been actively pursued to circumvent the enzyme barrier, with some of them receiving promising results. Yet, thus far there has been no major success in overcoming the mucosal barrier, which is the main cause in undercutting insulin’s oral bioavailability. In this review of our group’s research, an innovative silica-based, mucoadhesive oral insulin formulation with encapsulated-insulin/cell penetrating peptide (CPP) to overcome both enzyme and mucosal barriers is discussed, and the preliminary and convincing results to confirm the plausibility of this oral insulin delivery system are reviewed. In vitro studies demonstrated that the CPP-insulin conjugates could facilitate cellular uptake of insulin while keeping insulin’s biologic functions intact. It was also confirmed that low molecular weight protamine (LMWP) behaves like a CPP peptide, with a cell translocation potency equivalent to that of the widely studied TAT. The mucoadhesive properties of the produced silica-chitosan composites could be controlled by varying both the pH and composition; the composite consisting of chitosan (25 wt-%) and silica (75 wt-%) exhibited the greatest mucoadhesion at gastric pH. Furthermore, drug release from the composite network could also be regulated by altering the chitosan content. Overall, the universal applicability of those technologies could lead to development of a generic platform for oral delivery of many other bioactive compounds, especially for peptide or protein drugs which inevitably encounter the poor bioavailability issues.
Charge-switchable zwitterionic polycarboxybetaine particle as an intestinal permeation enhancer for efficient oral insulin delivery

Yan Li,Weihong Ji,Huan Peng,Ruichen Zhao,Tianlu Zhang,Zhiguo Lu,Jun Yang,Ruiyuan Liu,Xin Zhang

DOI: https://doi.org/10.7150/thno.54176

IF: 11.6

2021-01-01

Theranostics

Abstract:Insulin, a peptide hormone, is one of the most common and effective antidiabetic drugs. Although oral administration is considered to be the most convenient and safe choice for patients, the oral bioavailability of insulin is very low due to the poor oral absorption into blood circulation. Intestinal epithelium is a major barrier for the oral absorption of insulin. Therefore, it is vital to develop intestinal permeation enhancer to increase the antidiabetic efficacy of insulin after oral administration.Methods: Charge-switchable zwitterionic polycarboxybetaine (PCB) was used to load insulin to form PCB/insulin (PCB/INS) particles through the electrostatic interaction between positively charged PCB in pH 5.0 and negatively charged insulin in 0.01 M NaOH. The opening effect of PCB/INS particles on intestinal epithelium was evaluated by detecting the changes of claudin-4 (CLDN4) protein and transepithelial electrical resistance (TEER) after incubation or removal. The mechanism was further elucidated based on the results of Western blot and fluorescence images. The PCB/INS particles were then used for type 1 diabetes mellitus therapy after oral administration.Results: PCB could load insulin with the loading efficiency above 86% at weight ratio of 8:1. PCB/INS particles achieved sustained release of insulin at pH 7.4 due to their charge-switchable ability. Surprisingly, PCB/INS particles induced the open of the tight junctions of intestinal epithelium in endocytosis-mediated lysosomal degradation pathway, which resulted in increased intestinal permeability of insulin. Additionally, the opening effect of PCB/INS particles was reversible, and the decreased expression of CLDN4 protein and TEER values were gradually recovered after particles removal. In streptozotocin-induced type 1 diabetic rats, oral administration of PCB/INS particles with diameter sub-200 nm, especially in capsules, significantly enhanced the bioavailability of insulin and achieved longer duration of hypoglycemic effect than the subcutaneously injected insulin. Importantly, there was no endotoxin and pathological change during treatment, indicating that PCB/INS particles were safe enough for in vivo application.Conclusion: These findings indicate that this system can provide a platform for oral insulin and other protein drugs delivery.

medicine, research & experimental
Enhancing Insulin Oral Absorption by Using Mucoadhesive Nanoparticles Loaded with LMWP-linked Insulin Conjugates.

Jianyong Sheng,Huining He,Limei Han,Jing Qin,Sunhui Chen,Ge Ru,Ruixiang Li,Pei Yang,Jianxin Wang,Victor C. Yang

DOI: https://doi.org/10.1016/j.jconrel.2016.05.015

IF: 11.467

2016-01-01

Journal of Controlled Release

Abstract:Although significant progress has been achieved, effective oral delivery of protein drugs such as insulin by nanoparticle-based carrier systems still faces certain formidable challenges. Considerable amount of protein drug is released from the nanoparticles (NPs) in the gastrointestinal (GI) tract. Because of their low permeability through the intestinal mucosa, the released protein would be soon degraded by the large amount of proteases in the GI tract. Herein, we report an oral insulin delivery system that can overcome the above-mentioned problems by mucoadhesive NPs (MNPs) loaded with cell penetrating peptide-linked insulin conjugates. On one hand, after conjugation with low molecular weight protamine (LMWP), a cell penetrating peptide (CPP), insulin showed greatly improved permeability through intestinal mucus layer and epithelia. On the other hand, the mucoadhesive N-trimethyl chitosan chloride-coated PLGA nanoparticles (MNPs) that were loaded with conjugates enhanced the retention in the intestinal mucus layer. By adopting this delivery strategy, the LMWP-insulin conjugates released from the MNPs could be deprived from enzymatic degradation, due to the short distance in reaching the epithelia and the high permeation of the conjugates through epithelia. The oral delivery system of insulin designed by us showed a long-lasting hypoglycemia effect with a faster onset in diabetic rats. The pharmacological availability of orally delivered conjugates-loaded MNPs was 17.98±5.61% relative to subcutaneously injected insulin solution, with a 2-fold higher improvement over that by MNPs loaded with native insulin. Our results suggested that conjugation with CPP followed by encapsulation in MNPs provides an effective strategy for oral delivery of macromolecular therapeutics.
Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin

Fei Yu,Yang Li,Chang Sheng Liu,Qin Chen,Gui Huan Wang,Wei Guo,Xue E Wu,Dong Hui Li,Winston Duo Wu,Xiao Dong Chen

DOI: https://doi.org/10.1016/j.ijpharm.2015.02.055

2015-04-30

Abstract:The success of the oral delivery of insulin (INS) as a therapeutic protein drug would significantly improve the quality of life of diabetic patients who would otherwise receive multiple daily INS injections. The oral delivery of INS, however, is still limited in its delivery efficiency, which could be due to the chemical, enzymatic, and adsorption barriers. In this work, in an attempt to improve the delivery efficiency, the INS-loaded polymer-lipid hybrid nanoparticles (INS-PLGA-lipid-PEG NPs) were designed and constructed through a double-emulsion solvent evaporation technique, followed by formulation of the spherical micro-particles using a spray freeze dryer (SFD). This kind of dryers has a uniquely designed microfluidic aerosol nozzle (MFAN), ensuring the formation of uniform particles. The resulted particles of ∼212 μm could easily be reverted to discrete INS-PLGA-lipid-PEG NPs in an aqueous solution. The INS-PLGA-lipid-PEG NPs created in this work showed a highly negative surface charge, excellent entrapment efficiency (92.3%) and a sustained drug release (∼24 h). Confocal laser scanning microscopy and flow cytometer were used to show that the cellular uptake efficiency for the INS-PLGA-lipid-PEG NPs was more effective than the INS in Caco-2 cells. More importantly, the in vivo pharmacodynamics demonstrated that the orally delivered system induced a prolonged decrease in blood glucose levels among diabetic rats. The relative bioavailability of INS compared with subcutaneous injection in diabetic rats was found to be approximately 12%. These results suggested that the encapsulated INS-PLGA-lipid-PEG NPs are promising and should be investigated further in the near future as an effective INS oral delivery system.
Modulation of the activity of hepatic gamma-glutamyl transpeptidase, adenosine triphosphatase, placental glutathione S-transferase and adenylate cyclase by acute administration of lead nitrate.

A. Columbano,G. Ledda-Columbano,M. Ennas,M. Curto,M. D. De Montis,M. W. Roomi,P. Pani,D. Sarma

Abstract:The effect of a single administration of lead nitrate on the activity of gamma-glutamyltranspeptidase (gamma-GT), adenosine triphosphatase (ATPase), the placental form of glutathione S-transferase (GST-P) and adenylate cyclase (AC), four enzymes widely used as phenotypic markers for preneoplasia, was investigated in the liver of male Wistar rats. The results of the histochemical enzymatic staining indicated that an acute treatment with lead nitrate induces the activity of gamma-GT, mainly in the hepatocytes located around zone I of the liver acinus, with a maximum seen between 72-96 hours. On the other hand, the activity of ATPase was found to be severely inhibited at 2-3 days after treatment, as shown by a strong decrease in the staining of the bile canaliculi of zones II and III. Immunohistochemical analysis revealed that lead nitrate administration also resulted in the appearance in most of the hepatocytes of GST-P, an enzyme whose activity is almost undetectable in normal rat liver, but is elevated in preneoplastic liver lesions. Finally, lead nitrate treatment resulted in an inhibition of AC activity which was maximal after 24 hours.
Construction and functional evaluation of oral long-acting insulin hydrogel microparticles based on physical and chemical double crosslinking

ShengQin Chen,QingYa Miao,Yang Liu,Qiao Xiao,YuKai Lin,Yu Yang,FengBiao Guo

DOI: https://doi.org/10.1016/j.ijbiomac.2023.126915

IF: 8.2

2023-12-01

International Journal of Biological Macromolecules

Abstract:The objective of this study was to enhance the convenience and effectiveness of diabetes treatment by developing hydrogel microparticles as an oral insulin delivery system, aiming to reduce the necessity for frequent treatments. The hydrogel microparticles were prepared with polysaccharides through a combination of physical and chemical crosslinking method, they achieved good results in insulin loading efficiency (70 %), insulin release efficiency (98 %) and sustained release time (>20 h). The effective transmembrane transport was validated using an intestinal epithelial cell model, which demonstrated a continuous hypoglycemic effect lasting from 6 to 26 h in a type 2 diabetes mouse model. Additionally, the relative bioavailability of insulin reached 30.14 ± 2.62 %, representing a significant breakthrough in the field of oral insulin delivery carriers. Furthermore, oral insulin hydrogel exhibited a substantial improvement in insulin resistance, organ damage, and diabetes-related complications stemming from hyperglycemia. These compelling findings underscore the potential of hydrogel microparticles as a cost-effective and valuable strategy for oral drug delivery in diabetes treatment.

polymer science,biochemistry & molecular biology,chemistry, applied
β-Cyclodextrin/dialdehyde glucan-coated keratin nanoparticles for oral delivery of insulin

Yunyun Wang,Wangdi Song,Shengnan Xue,Yue Sheng,Bo Gao,Yanyan Dang,Yan Zhang,Genlin Zhang

DOI: https://doi.org/10.1016/j.ijbiomac.2024.133805

Abstract:Successful oral insulin administration can considerably enhance the quality of life (QOL) of diabetes patients who must frequently take insulin injections. However, Oral insulin administration is seriously hampered by gastrointestinal enzymes, wide pH range, mucus and mucosal layers, which limit insulin oral bioavailability to ≤2 %. Herein, we developed a simple, inexpensive and safe dual β-cyclodextrin/dialdehyde glucan-coated keratin nanoparticle (β-CD-K-IN-DG). The resulted β-CD-K-IN-DG not only gave the ultra-high insulin loading (encapsulation efficiency (98.52 %)), but also protected insulin from acid and enzymatic degradation. This β-CD-K-IN-DG had a notable hypoglycemic effect, there was almost 80 % insulin release after 4 h of incubation under hyperglycemic conditions. Ex vivo results confirmed that β-CD-K-IN-DG possessed high mucus-penetration ability. Transepithelial transport and uptake mechanism studies revealed that bypass transport pathway and endocytosis promoted β-CD-K-IN-DG entered intestinal epithelial cells, thus increased the bioavailability of insulin (12.27 %). The improved stability of insulin during in vivo transport implied that β-CD-K-IN-DG might be a potential tool for the effective oral insulin administration.
Preparation and evaluation of insulin-loaded nanoparticles based on hydroxypropyl-β-cyclodextrin modified carboxymethyl chitosan for oral delivery

Haoyuan Song,Xiaoling Ma,Fuliang Xiong,Hui Hong,Chunfu Li,Lianghong Li,Shanshan Wu,Xueqiong Zhang,Juan Zhang,Jianhua Hu

DOI: https://doi.org/10.1007/s11595-016-1544-z

2016-12-01

Abstract:Novel insulin-loaded nanoparticles based on hydroxypropyl-β-cyclodextrin modified carboxymethyl chitosan (CMC-HP-β-CD) were prepared to improve the oral bioavailability of insulin. The CMC-HP-β-CD was characterized by FT-IR spectroscopy and 1H-NMR spectra. The insulin-loaded nanoparticles were prepared through crosslinking with calcium ions, and the morphology and size of the prepared nanoparticles were characterized by transmission electron microscopy (TEM) and dynamic light scattering (DLS). Cumulative release in vitro study was performed respectively in simulated gastric medium fluid (SGF, pH=1.2), simulated intestinal fluid (SIF, pH=6.8) and simulated colonic fluid (SCF, pH=7.4). The encapsulation efficiency of insulin was up to 87.14 ± 4.32% through high-performance liquid chromatography (HPLC). Statistics indicated that only 15% of the encapsulated insulin was released from the CMC-HP-β-CD nanoparticles in 36 h in SGF, and about 50% of the insulin could be released from the nanoparticles in SIF, whereas more than 80% was released in SCF. In addition, the solution containing insulin nanoparticles could effectively reduce the blood glucose level of diabetic mice. The cytotoxicity test showed that the samples had no cytotoxicity. CMC-HP-β-CD nanoparticles are promising candidates as potential carriers in oral insulin delivery systems.

materials science, multidisciplinary
Protein Corona Liposomes Achieve Efficient Oral Insulin Delivery by Overcoming Mucus and Epithelial Barriers

Aohua Wang,Tiantian Yang,Weiwei Fan,Yiwei Yang,Quanlei Zhu,Shiyan Guo,Chunliu Zhu,Yongchun Yuan,Tao Zhang,Yong Gan

DOI: https://doi.org/10.1002/adhm.201801123

IF: 10

2018-11-28

Advanced Healthcare Materials

Abstract:Abstract Oral delivery of peptide/protein drugs has attracted worldwide attention due to its good patient compliance and convenience of administration. Orally administered nanocarriers always encounter the rigorous defenses of the gastrointestinal tract, which mainly consist of mucus and epithelium barriers. However, diametrically opposite surface properties of nanocarriers are required for good mucus penetration and high epithelial uptake. Here, bovine serum albumin (BSA) is adsorbed to cationic liposomes (CLs) to form protein corona liposomes (PcCLs). The aim of using PcCLs is to conquer the mucus and epithelium barriers, eventually improving the oral bioavailability of insulin. Investigations using in vitro and in vivo experiments show that the uptake amounts and transepithelial permeability of PcCLs are 3.24‐ and 7.91‐fold higher than that of free insulin, respectively. Further study of the behavior of PcCLs implies that BSA corona can be shed from PcCLs as they cross the mucus layer, which results in the exposure of CLs to improve the transepithelial transport. Intrajejunal administration of PcCLs in type I diabetic rats produces a remarkable hypoglycemic effect and increases the oral bioavailability up to 11.9%. All of these results imply that PcCLs may provide a new insight into the method for oral insulin delivery by overcoming the multiple barriers.

nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials
National grassroots strategic planning for NIMH: you can be a part of it.

E. Poster

DOI: https://doi.org/10.1111/J.1744-6171.2000.TB00085.X

2000-07-01

Journal of Child and Adolescent Psychiatric Nursing

Abstract:
Preparation and characterization of CS/γ-PGA/PC complex nanoparticles for insulin oral delivery

Kedong Liu,Yun Chen,Zhaoqi Yang,Jian Jin

DOI: https://doi.org/10.1007/s00396-023-05078-1

2023-03-14

Abstract:In recent years, natural polyelectrolyte complex chitosan/poly-γ-glutamic acid (CS/γ-PGA) has emerged as a promising nanocarrier delivery system for drug delivery due to its non-toxic and easily degradable properties. However, tightly bound CS/γ-PGA complexes often lead to lower encapsulation efficiency of peptide drugs without coordination of metal ions. In this investigation, we find that procyanidin (PC), as a cross-linking agent, is able to combine with CS and insulin through hydrogen bonding, which significantly improve encapsulation efficiency of insulin up to 90% in CS/γ-PGA/PC complex nanoparticles (CNPs). The results of this study demonstrate that CNPs release insulin in a pH-dependent approach and greatly reduce its enzymatic degradation in vitro. The transepithelial permeability of the CNPs is 8.1-fold higher than that of native insulin via both endocytosis and paracellular passways. Further pharmacokinetic studies reveal an oral pharmacological availability of 9.81 ± 1.32% in type I diabetic rats after intragastric administration of freeze-dried CNPs which loaded in enteric-coated capsules. In consequence, CNPs not only improve oral bioavailability of insulin but also are a promising delivery platform for insulin or other peptide/protein drugs.

polymer science,chemistry, physical
Urease Catalyzed High-Density Sodium Alginate Microspheres Enables High Oral Bioavailability of Macromolecular Drugs

Yicheng Jiang,Li Mi,Xiang Xu,Adric Ru Khiing Hii,Zhenghong Wu,Xiaole Qi

DOI: https://doi.org/10.1039/d3bm01715j

2024-01-19

Biomaterials Science

Abstract:Destruction of insulin caused by the gastric microenvironment and rapid gastric clearance pose inevitable barriers to oral macromolecular absorption, especially for most peptide and protein drugs. In this study, we developed high-density sodium alginate microspheres composed of magnesium oxide and urease to address these challenges. These microspheres aim to anchor gastric mucus layer and induce microenvironmental liquefaction, thereby enhancing gastric retention and protection of insulin. The sedimentation test confirmed the capability of the Ins/Ur/MgO@SA microsphere to rapidly penetrate the gastric mucus layer under the influence of gravity. Additionally, the urease immobilized on the Ins/Ur/MgO@SA microspheres catalyzes the hydrolysis of urea in the mucus and promotes the liquefaction of mucus, which is beneficial to microsphere retention. The inclusion of MgO particles and urease, acting as pHM modifiers, helps in adjusting the local pH to avoid gastric acid-induced damage. Subsequently, an in vivo pharmacokinetic experiments verified that the relative bioavailability of p.o. Ins/Ur/MgO@SA treated group was 15-fold higher than that of the p.o. Insulin treated group. Meanwhile, the satisfied blood glucose levels (BGLs) reduction was observed in diabetic animals. In conclusion, Ins/Ur/MgO@SA microspheres demonstrate high biocompatibility as insulin carriers with prolonged drug release time and increased gastric retention properties, showing a far-reaching strategy for oral macromolecular drug delivery.

materials science, biomaterials
Development of polysaccharide-coated layered double hydroxide nanocomposites for enhanced oral insulin delivery

Huiwen Pang,Youzhi Wu,Yang Chen,Chen Chen,Xuqiang Nie,Peng Li,Guojun Huang,Zhi Ping Xu,Felicity Y Han

DOI: https://doi.org/10.1007/s13346-023-01504-7

Abstract:Oral insulin (INS) is predicted to have the most therapeutic advantages in treating diabetes to repress hepatic glucose production through its potential to mimic the endogenous insulin pathway. Many oral insulin delivery systems have been investigated. Layered double hydroxide (LDH) as an inorganic material has been widely used in drug delivery thanks to its appealing features such as good biocompatibility, low toxicity, and excellent loading capability. However, when used in oral drug delivery, the effectiveness of LDH is limited due to the acidic degradation in the stomach. In this study, to overcome these challenges, chitosan (Chi) and alginate (Alg) dual-coated LDH nanocomposites with the loading of insulin (Alg-Chi-LDH@INS) were developed by the layered-by-layered method for oral insulin delivery with dynamic size of ~ 350.8 nm, negative charge of ~ - 13.0 mV, and dispersity index 0.228. The insulin release profile was evaluated by ultraviolet-visible spectroscopy. The drug release profiles evidenced that alginate and chitosan coating partially protect insulin release from a burst release in acidic conditions. The analysis using flow cytometry showed that chitosan coating significantly enhanced the uptake of LDH@INS by Caco-2 cells compared to unmodified LDH and free insulin. Further in the in vivo study in streptozocin-induced diabetic mice, a significant hypoglycemic effect was maintained following oral administration with great biocompatibility (~ 50% blood glucose level reduction at 4 h). This research has thus provided a potential nanocomposite system for oral delivery of insulin.
Glucose-responsive oral insulin delivery platform for one treatment a day in diabetes

Yufen Xiao,Zhongmin Tang,Xiangang Huang,John Joseph,Wei Chen,Chuang Liu,Jun Zhou,Na Kong,Nitin Joshi,Jianzhong Du,Wei Tao

DOI: https://doi.org/10.1016/j.matt.2021.08.011

IF: 18.9

2021-10-01

Matter

Abstract:Oral delivery of insulin is of great convenience in treating diabetes but is still subject to the harsh gastrointestinal tract. Herein, we developed an intelligent oral insulin platform based on glucose-responsive polymeric nanoparticles (NPs), which possess the following advantages: (1) protect the integrity and bioavailability of loaded insulin against gastrointestinal tract, (2) overcome the intestinal epithelial barriers via neonatal Fc receptor-mediated transport, and (3) on-demand release of insulin dependent solely on blood glucose levels to avoid hyperglycemia and hypoglycemia caused by unsafe doses of insulin. Notably, our oral NPs extended the therapeutic effect to up to 16 h in type 1 diabetic mice. To our knowledge, this is the longest effective time among such types of oral insulin platforms reported to date and may reduce the frequency of insulin administration to once daily. This platform might be useful for the oral delivery of biologics in treating diabetes and related complications.

materials science, multidisciplinary
Chitosan modified cerasomes incorporating poly (vinyl pyrrolidone) for oral insulin delivery

yushen jin,hongjie pan,yanyan li,zhifei dai

DOI: https://doi.org/10.1039/c4ra09771h

IF: 4.036

2014-01-01

RSC Advances

Abstract:The most significant finding of this study is that a hybrid liposomal cerasome with high stability and good biocompatibility was successfully developed for oral insulin delivery by incorporating poly (vinyl pyrrolidone) (PVP) into the cerasome followed by coating with chitosan (CS). These PVP and CS modified cerasomes (PCCs) were positively charged with an average size of about 247.8 +/- 3.3 nm. It was found that insulin-loaded PCCs could maintain their size and retain the encapsulated insulin over a period of 90 days, suitable for uptake within the gastrointestinal tract. PCCs had an encapsulation efficiency of 82.03 +/- 7.53% and drug loading content of 0.36 +/- 0.03 (g g(-1)), much higher than that of unmodified cerasomes (45.91 +/- 1.87% and 0.27 +/- 0.01 (g g(-1))). The in vitro experiments showed that less than 65% insulin was released from PCCs after 160 h under physiological conditions. The oral administration of insulin-loaded unmodified cerasomes resulted in almost no change in blood glucose levels in hyperglycemic rats. On the contrary, the insulin-loaded PCCs rapidly decreased the plasma glucose levels which reached their maximum around 2 h (17.15% from the initial value) after oral administration. Especially, the insulin-loaded PCCs displayed a prolonged and stable glucose-lowering profile over a period of over 10 h. Both the PVP and the CS can increase the half life of the cerasomes in vivo. In addition, CS as a mucoadhesive polymer can open tight junctions of intestinal epithelial layers, resulting in high oral bioavailability. In other words, the PCCs have great potential as oral formulations for delivering therapeutic protein or peptide drugs.
Controlled release and hypoglycemic effect of insulin microcapsules constructed by dextran sulphate and ferricion

Zheng Jian,Yue Xiu-li,Wang Yang,Liu Shao-qin,Dai Zhi-fei

DOI: https://doi.org/10.3321/j.issn:1673-8225.2008.36.019

2008-01-01

Abstract:BACKGROUND: It is feasible to prepare the microsphere delivery system of protein and polypeptide drugs including insulin, by various proteolytic enzymes. This system may overcome such disadvantages as poor stability, short half-life time and the inactivation resuled in hydrolysis. OBJECTIVE: To construct an insulin controlled microcapsule, and to investigate its in vitro controlled release and in vivo hypoglycemic effect. DESIGN, TIME AND SETTING: A controlled observation experiment was performed in Nanomedicine and Biosensor Laboratory Bio-X Center, Harbin Institute of Technology between May 2007 and January 2008. MATERIALS: Male Wistar rats were used to establish diabetes mellitus models by the intraperitoneal injection of streptozotocin. An insulin controlled microcapsule was fabricated by layer-by-layer self-assembly of dextran sulphate and ferric ion via electrostatic interaction. METHODS: The release effect of insulin-loaded microcapsules was detected by in vitro test. Eighteen diabetes mellitus models were divided into three groups randomly, and received subcutaneous injections of insulin 5 U/kg, subcutaneous injections of insulin 100 U/kg, and intragastric administration of insulin-loaded microcapsules 100 U/kg, respectively. MAIN OUTCOME MEASURES: The encapsulation efficiency, drug loading content, in vitro release behavior and in vivo hypoglycemic effect of the insulin-loaded microcapsules were all assessed. RESULTS: The encapsulation efficiency and drug loading content of the insulin-loaded microcapsules were higher than 60% and 40%, respectively. The results of in vitro insulin releasing test displayed good release behavior, and drug release speed stepped down with the increase of encapsulation layers. The in vivo hypoglycemic effect study showed the insulin-loaded microcapsules significantly improved glucose tolerance to 6-10 hours by subcutaneous injection, while no effect was found after intragastric administration. CONCLUSION: Fabricated by layer-by-layer self-assembly of dextran sulphate and ferric ion via electrostatic interaction, the insulin-loaded microcapsules have a better stability, and could maintain the hypoglycemic effect for a long time.

Semaphorin 7A on keratinocytes induces interleukin-8 production by monocytes.

Preparation of chitosan-based multifunctional nanocarriers overcoming multiple barriers for oral delivery of insulin.

Dually-crosslinked Degradable Polyionic Micelles for Sustained Glucose-responsive Insulin Release

Zwitterionic micelles efficiently deliver oral insulin without opening tight junctions

A nano-delivery system based on preventing degradation and promoting absorption to improve the oral bioavailability of insulin

Overcoming Oral Insulin Delivery Barriers: Application of Cell Penetrating Peptide and Silica-Based Nanoporous Composites

Charge-switchable zwitterionic polycarboxybetaine particle as an intestinal permeation enhancer for efficient oral insulin delivery

Enhancing Insulin Oral Absorption by Using Mucoadhesive Nanoparticles Loaded with LMWP-linked Insulin Conjugates.

Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin

Modulation of the activity of hepatic gamma-glutamyl transpeptidase, adenosine triphosphatase, placental glutathione S-transferase and adenylate cyclase by acute administration of lead nitrate.

Construction and functional evaluation of oral long-acting insulin hydrogel microparticles based on physical and chemical double crosslinking

β-Cyclodextrin/dialdehyde glucan-coated keratin nanoparticles for oral delivery of insulin

Preparation and evaluation of insulin-loaded nanoparticles based on hydroxypropyl-β-cyclodextrin modified carboxymethyl chitosan for oral delivery

Protein Corona Liposomes Achieve Efficient Oral Insulin Delivery by Overcoming Mucus and Epithelial Barriers

National grassroots strategic planning for NIMH: you can be a part of it.

Preparation and characterization of CS/γ-PGA/PC complex nanoparticles for insulin oral delivery

Urease Catalyzed High-Density Sodium Alginate Microspheres Enables High Oral Bioavailability of Macromolecular Drugs

Development of polysaccharide-coated layered double hydroxide nanocomposites for enhanced oral insulin delivery

Glucose-responsive oral insulin delivery platform for one treatment a day in diabetes

Chitosan modified cerasomes incorporating poly (vinyl pyrrolidone) for oral insulin delivery

Controlled release and hypoglycemic effect of insulin microcapsules constructed by dextran sulphate and ferricion